HPLC / UPLC Testing
High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) are industry-standard methods used to evaluate peptide purity and detect impurities.
Quality goes beyond a certificate or a single purity result. Explore how manufacturing, laboratory testing, supplier evaluation and ongoing quality oversight fit together.
At PROPeptides, quality is not determined by a single test result or certificate. Quality is the result of careful manufacturer selection, rigorous supplier qualification, comprehensive analytical testing, batch consistency, and a commitment to continuous improvement.
The peptide industry continues to evolve rapidly. Manufacturing technologies, testing methodologies, quality expectations, and regulatory frameworks are becoming more sophisticated every year. As the industry advances, so do our standards.
We are committed to sourcing only from manufacturers and partners that meet our internal qualification requirements. Every manufacturer undergoes evaluation of their quality systems, manufacturing practices, sourcing procedures, testing capabilities, consistency, documentation, and overall reliability before being considered for our supply chain.
Whenever possible, we prioritize:
Provide the highest quality peptide products available while continuously raising our standards as science, manufacturing, and industry best practices evolve.
Not all peptide products are manufactured or tested to the same standard.
The phrase "tested peptide" can mean very different things depending on the manufacturer, testing performed, production environment, and intended use.
Some products originate from specialized peptide manufacturing laboratories utilizing advanced peptide synthesis and analytical testing. Other products originate from licensed compounding pharmacies or FDA-registered outsourcing facilities that operate under additional sterile compounding and quality-control requirements.
Understanding these differences helps consumers make informed decisions about quality, testing, and manufacturing standards.
Our guide distinguishes verified peptide manufacturing, ISO-supported laboratory quality systems, and pharmacy-sourced products. These are descriptive categories, not interchangeable certifications or guarantees that every test was performed.
This category represents manufacturers that utilize established peptide synthesis processes and perform comprehensive analytical testing to verify product quality and consistency.
Typical testing may include:
High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) are industry-standard methods used to evaluate peptide purity and detect impurities.
Mass spectrometry confirms molecular weight and helps verify that the peptide produced matches the intended molecular structure.
Each production batch is reviewed to confirm consistency and acceptable quality characteristics.
Independent laboratories may be utilized to verify testing results and provide additional confidence in analytical findings.
Depending on the manufacturer and product, this level of testing may not automatically include:
These additional quality controls are more commonly associated with sterile pharmaceutical manufacturing and pharmacy compounding environments.
Certain manufacturers utilize laboratories that operate under internationally recognized quality standards.
ISO refers to standards established by the International Organization for Standardization.
For analytical laboratories, the most relevant accreditation is:
ISO 17025 is considered the international gold standard for testing laboratory competence.
An ISO 17025 accredited laboratory must demonstrate:
This accreditation provides confidence that testing is being performed according to validated procedures with documented quality controls.
ISO accreditation does not mean:
Rather, ISO accreditation demonstrates that the laboratory performing the testing has established systems designed to produce reliable and repeatable analytical results.
Certain PROPeptides products are sourced through licensed compounding pharmacies and FDA-registered outsourcing facilities.
These products undergo additional manufacturing and quality controls that may exceed what is typically performed for standard peptide manufacturing.
A 503A pharmacy is a licensed compounding pharmacy that prepares medications pursuant to a valid prescription for an individually identified patient.
503A pharmacies operate under pharmacy compounding regulations and sterile compounding standards where applicable.
A 503B outsourcing facility is an FDA-registered outsourcing facility that compounds medications under additional manufacturing and quality requirements.
503B facilities are subject to:
While compounded products are not FDA-approved medications, 503B outsourcing facilities operate under significantly enhanced manufacturing oversight.
Depending on the product and source, pharmacy-produced products may undergo additional testing and quality review including:
Sterility testing evaluates whether viable microorganisms are present within the final product.
This is especially important for injectable products.
Endotoxin testing evaluates bacterial endotoxins that can trigger inflammatory or immune reactions even in the absence of live bacteria.
Potency testing confirms that the labeled amount of active ingredient is present within acceptable specifications.
Verifies the active ingredient matches the intended compound.
Evaluates the percentage of intended peptide relative to impurities or degradation products.
Evaluates whether product strength, purity, and quality remain acceptable throughout storage.
Monitors cleanroom environments and manufacturing conditions.
Verifies competency and training of personnel involved in sterile production.
Maintains traceability throughout manufacturing and quality review processes.
Provides additional oversight before product release.
One of the most common misconceptions in the peptide industry is that purity percentage alone determines quality.
A peptide may demonstrate excellent purity while still lacking other important quality controls.
True quality is determined by the entire manufacturing and testing process—not a single purity number.
Individual tests answer different questions about the identity, composition, microbial quality and stability of a product.
Confirms that the intended peptide is present.
Typically performed through mass spectrometry and other analytical methods.
Measures the percentage of desired peptide relative to impurities.
Most commonly performed through HPLC or UPLC analysis.
Measures the actual quantity of active ingredient present.
Confirms molecular weight and peptide identity.
Evaluates for viable microbial contamination.
Measures bacterial endotoxin levels.
Evaluates contamination from metals such as:
Evaluates manufacturing solvent residues.
Determines product performance over time under specified storage conditions.
Evaluates whether packaging maintains its protective barrier throughout storage.
Lead, Arsenic, Mercury, Cadmium. Testing scope and acceptance criteria depend on the applicable product and laboratory method.
Compare commonly associated quality practices across manufacturing and testing settings.
| QUALITY ELEMENT | VERIFIED MANUFACTURING | ISO SUPPORTED TESTING | PHARMACY-SOURCED PRODUCTS |
|---|---|---|---|
| Identity Testing | ✓ | ✓ | ✓ |
| Purity Testing | ✓ | ✓ | ✓ |
| Mass Spectrometry | ✓ | ✓ | ✓ |
| Third-Party Testing | Often | Common | Common |
| ISO Laboratory Support | Optional | ✓ | Often |
| Potency Testing | Sometimes | Sometimes | Common |
| Heavy Metals Testing | Manufacturer Dependent | Often Available | Risk-Based |
| Residual Solvents | Manufacturer Dependent | Often Available | Risk-Based |
| Sterility Testing | May Vary | May Vary | Common |
| Endotoxin Testing | May Vary | May Vary | Common |
| Environmental Monitoring | No | No | Yes |
| Stability Programs | Limited | Enhanced | Extensive |
| Batch Release Procedures | Basic | Enhanced | Extensive |
| Quality Assurance Review | Standard | Enhanced | Extensive |
This is a general comparison of commonly associated practices, not proof of testing performed on any individual lot. Request product-specific records where needed.
Before partnering with any supplier, we evaluate:
Our goal is not simply to identify manufacturers that meet today's standards.
Our goal is to identify manufacturers committed to meeting tomorrow's standards as well.
The peptide industry is advancing at an unprecedented pace.
Manufacturing technologies are improving.
Testing methodologies are becoming more sophisticated.
Regulatory expectations continue to evolve.
Quality standards continue to rise.
As these improvements occur, PROPeptides remains committed to continuously evaluating and strengthening our own quality expectations.
We believe quality is not a destination—it is an ongoing process of improvement.
By combining careful supplier selection, comprehensive testing, transparent quality practices, pharmacy partnerships, and a commitment to continuous advancement, we strive to provide products that meet the highest standards available within their respective manufacturing categories.
It begins with sourcing.
It continues through manufacturing.
It is verified through testing.
It is strengthened through accountability.
And it improves through continuous refinement.
At PROPeptides, our mission is to partner only with manufacturers that share those same principles and to continually elevate our standards as the peptide industry continues to mature.